[Congress] Meet2Win – 21- 22 May - Bordeaux - France

Meet2Win –May  21- 22 – Bordeaux

Our experts will be present:

  • Round table "Quoi de neuf autour de l’innovation en oncologie ?"  with the participation of Mr. Sébastien Vachenc - Head of the Data Sciences Lab and OncoSNIPE® Program Director.
  • As participant to networking sessions to unveil our competencies in oncology/IO with our consortium IMODI and our broader panel of offerings in inflammatory & infectious diseases (from target identification, lead optimization to IND).



I fix a meeting! 

[Congress] Knowledge For Growth - 9 May - Ghent - Belgium

Knowledge For Growth – 9 May – Ghent

Come & see Jan Hoflack - CSO & Keith Payne – Business Development Manager, during the Annual Life Sciences Conference Knowledge for Growth in Ghent.

This high-level networking event attracts decision makers from biotech, pharma & medtech as well as investors, universities, topnotch research institutes, policy makers & competence providers.

Checkout our unique drug discovery platform from patient to diagnostic & therapeutic solution.

Discover our Nanocyclix pipeline of next generation macrocyclic kinase inhibitors.

Discuss our broad service offering of innovative solutions & our licensing or partnership opportunities in oncology, immuno-inflammation & neurodegenerative diseases for licensing or partnerships. 

 I fix  a meeting!

[Forum] [FR] Market Solutions Forum by ESN - 4 April - Palais Brognart - Paris -France

[Forum] [FR] Market Solutions Forum by ESN - 4 Avril - Palais Brognart

A leading Forum where more than 200 European companies will meet with 300 investors!  

Discover the agenda








[Congress] 2019 ACS - 31 March - 4 April - Orlando - USA

 ACS 31 March – 4 April – Orlando 


Nanokinib: a cyclic library of hinge binder. A chemocentric approach for the discovery of selective kinases inhibitor.
When: 31 March -  5pm-7pm

I read the abstract!


By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.